Nov 12, 2009

TIME.com Top Blog Posts Giving Tamiflu to patients who may have been exposed to swine flu -- such as family members of confirmed cases -- as a preventive measure, may result in their developing drug-resistant strains of the virus. (Read More)

6 days ago

Submitted by Profvrr from blog: Vincent, Dick, Alan and emergency medicine physician Dr. Joshua Stillman talk about passive antibody therapy for Nipah infection in ferrets, immunization and facemasks to prevent influenza, dengue, and the amazing viral communities in an Antarctic lake. (Read More)

Nov 08, 2009

Submitted by Profvrr from blog: Vincent visited Scotch Plains - Fanwood High School and talked about viruses with high school biology students. (Read More)

Nov 01, 2009

Submitted by Profvrr from blog: Vincent, Dick, Alan, and Cliff answer questions from listeners on swine influenza origins, transmission, virulence, and vaccines, HIV and AIDS, and more. (Read More)

Oct 25, 2009

Submitted by Profvrr from blog: The largest TWiV panel ever takes on XMRV and chronic fatigue, chemistry Nobel prizes for ribosome structure, new poxvirus vaccine candidates, brouhaha over leaked Canadian data on flu susceptibility, and transmission of H1N1 influenza to a pet ferret. (Read More)

Oct 18, 2009

Submitted by Profvrr from blog: Vincent speaks with Lynn Enquist about his career in virology, moving from academia to industry and back. Along the way he did pioneering research on bacteriophage, participated in the birth of recombinant DNA technology, and studied herpesviruses. (Read More)

Oct 11, 2009

Submitted by Profvrr from blog: Vincent, Dick, and Alan talk about Nobel prizes for telomere research, bacteriophages that protect aphids from wasps, salicylates and pandemic influenza mortality, and hand washing. (Read More)

Oct 07, 2009

Wall Street Journal BOSTON (MarketWatch) -- Baxter International said Wednesday that European Union regulators have approved its Celvapan vaccine for the H1N1, or swine, flu virus. The vaccine uses Baxter's new cell-based culturing technology, which can produce influenza vaccine within 12 weeks. Current flu vaccine technologies generally have (Read More)

Oct 04, 2009

Submitted by Profvrr from blog: Vincent and Dr. Scott Hammer talk about different types of AIDS vaccines and how they are tested in clinical trials. (Read More)

Sep 27, 2009

Submitted by Profvrr from blog: Vincent, Dick, and Alan (cameo appearance by Rich Condit) review world’s largest Phase III study of an HIV vaccine candidate in Thailand, immunization of salmon against infectious salmon anemia virus, and an outbreak of blueberry shock virus in Michigan. (Read More)

Vincent Racaniello